Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy design for maximizing sensitivity and minimizing toxicity.

Kevin Matlock1, Noah Berlow2, Charles Keller2

  • 1Department of Electrical and Computer Engineering, Texas Tech University, 1012 Boston Ave, Lubbock, 79409, TX, USA.

BMC Bioinformatics
|April 1, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

System for study of diverse cellular composition in alveolar rhabdomyosarcoma.

Scientific reports·2026
Same author

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

British journal of cancer·2026
Same author

Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine Glioma.

ImmunoTargets and therapy·2026
Same author

A Pax7::Foxo1 conditional mouse strain.

Skeletal muscle·2026
Same author

Genomic Landscape of Myoepithelial Carcinoma Tumors.

Oral diseases·2026
Same author

Fetal imaging with microCT (µCT) in the age of AI.

Reproductive toxicology (Elmsford, N.Y.)·2026
Same journal

Model-based quantification of protein-protein interaction aberrations for exploring dysregulated signalling pathways through pathway maps and gene expression levels.

BMC bioinformatics·2026
Same journal

Research on multi-trait genome association study method based on Shannon information entropy.

BMC bioinformatics·2026
Same journal

A multi-view feature fusion framework with interpretable graph convolution for predicting microbe-drug associations.

BMC bioinformatics·2026
Same journal

Covariance decomposition for distance based species tree estimation.

BMC bioinformatics·2026
Same journal

SNPio: a Python interface for population genomic data processing.

BMC bioinformatics·2026
Same journal

SpaHNR: a spatial domain identification method via sparse attention-based hierarchical node representation and multi-view contrastive learning.

BMC bioinformatics·2026
See all related articles

This study introduces a new computational framework for designing personalized combination therapies. It optimizes drug effectiveness against tumor cells while minimizing toxicity to normal cells, addressing tumor heterogeneity.

Area of Science:

  • Computational Biology
  • Pharmacology
  • Bioinformatics

Background:

  • Personalized targeted therapies require modeling patient drug sensitivity.
  • Current approaches often neglect drug effects on normal cells, focusing solely on tumor cells.

Purpose of the Study:

  • To develop a method for designing combination therapies that individually model drug responses in tumor and normal cells.
  • To maximize tumor cell sensitivity while minimizing normal cell toxicity.

Main Methods:

  • Formulated the problem as optimizing tumor cell sensitivity under a toxicity constraint for normal cells.
  • Developed an accelerated lexicographic search algorithm for optimal solution generation.
  • Compared performance against evolutionary and hill-climbing algorithms.
Keywords:
Combination drug designLexicographic searchToxicity constraints

Related Experiment Videos

Main Results:

  • The proposed lexicographic search algorithm efficiently finds optimal or near-optimal drug combinations.
  • Achieved significantly fewer computational steps compared to exhaustive search methods.
  • Validated performance on synthetic and real-world cancer genomics data.

Conclusions:

  • The developed algorithms offer a robust framework for designing combination therapies.
  • Effectively addresses tumor heterogeneity and adheres to critical toxicity constraints.